Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155156237> ?p ?o ?g. }
- W2155156237 endingPage "5785" @default.
- W2155156237 startingPage "5785" @default.
- W2155156237 abstract "The crystal structures of two polymorphs and two polymorphic hemihydrates of Etoricoxib are reported. Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that is a selective inhibitor of COX-2. It is used in the treatment of various types of inflammation, pain and fever. Clas et al. have reported four polymorphs (labeled I through IV) and two solvates (hemi- and sesquihydrate) of the API in US patent 6,441,002 (Clas et al, US patent 6,441,002, 2002). However, no crystal structures have been reported for any of these forms. A comparison was made between the PXRD patterns reported in patent ’002 and the powder spectra simulated from single crystal data. The two polymorphs characterized here correspond to form I and form IV of the patent. Form II of the patent could not be obtained by us with a variety of experimental conditions. Form III of the patent corresponds to hemihydrate II of this study. Form III is therefore not a polymorph of form I and form IV. What we have termed hemihydrate I in this study is obtained under a wide variety of conditions and it is also the only hemihydrate reported as such in the patent. Because the Etoricoxib molecule contains no conventional hydrogen bond donors, there cannot be any strong hydrogen bonds in the crystal structures of forms I and IV. The packing is accordingly characterized by weak hydrogen bonds of the C–H⋯OS and C–H⋯N type. Thermal data were collected for form I, form IV and hemihydrate I to shed some light on relative stabilities. PXRD diffractograms show the transformation of form IV to form I at elevated temperature, indicating that form I is more stable than form IV. However, this transformation occurs only in samples of form IV that contain some form I; it does not occur in pure form IV. The formation of the two hemihydrates could follow from the known tendency of an acceptor-rich molecule to crystallize as a hydrate." @default.
- W2155156237 created "2016-06-24" @default.
- W2155156237 creator A5054702435 @default.
- W2155156237 creator A5060583781 @default.
- W2155156237 creator A5064424943 @default.
- W2155156237 date "2012-01-01" @default.
- W2155156237 modified "2023-09-23" @default.
- W2155156237 title "Polymorphs and hydrates of Etoricoxib, a selective COX-2 inhibitor" @default.
- W2155156237 cites W1484880768 @default.
- W2155156237 cites W1580142972 @default.
- W2155156237 cites W1967475900 @default.
- W2155156237 cites W1968324829 @default.
- W2155156237 cites W1973059245 @default.
- W2155156237 cites W1983875842 @default.
- W2155156237 cites W1987835305 @default.
- W2155156237 cites W1996042737 @default.
- W2155156237 cites W2003857515 @default.
- W2155156237 cites W2007353611 @default.
- W2155156237 cites W2012068802 @default.
- W2155156237 cites W2019328541 @default.
- W2155156237 cites W2020114620 @default.
- W2155156237 cites W2020247027 @default.
- W2155156237 cites W2021734604 @default.
- W2155156237 cites W2028699006 @default.
- W2155156237 cites W2029027756 @default.
- W2155156237 cites W2033683526 @default.
- W2155156237 cites W2045961350 @default.
- W2155156237 cites W2056570578 @default.
- W2155156237 cites W2063334178 @default.
- W2155156237 cites W2064981002 @default.
- W2155156237 cites W2067002519 @default.
- W2155156237 cites W2075511045 @default.
- W2155156237 cites W2081656744 @default.
- W2155156237 cites W2083265640 @default.
- W2155156237 cites W2116947993 @default.
- W2155156237 cites W2118947672 @default.
- W2155156237 cites W2154852821 @default.
- W2155156237 cites W2200746971 @default.
- W2155156237 cites W2312497560 @default.
- W2155156237 cites W2335434301 @default.
- W2155156237 cites W4247119413 @default.
- W2155156237 doi "https://doi.org/10.1039/c2ce06604a" @default.
- W2155156237 hasPublicationYear "2012" @default.
- W2155156237 type Work @default.
- W2155156237 sameAs 2155156237 @default.
- W2155156237 citedByCount "21" @default.
- W2155156237 countsByYear W21551562372015 @default.
- W2155156237 countsByYear W21551562372016 @default.
- W2155156237 countsByYear W21551562372017 @default.
- W2155156237 countsByYear W21551562372018 @default.
- W2155156237 countsByYear W21551562372019 @default.
- W2155156237 countsByYear W21551562372020 @default.
- W2155156237 countsByYear W21551562372021 @default.
- W2155156237 countsByYear W21551562372022 @default.
- W2155156237 countsByYear W21551562372023 @default.
- W2155156237 crossrefType "journal-article" @default.
- W2155156237 hasAuthorship W2155156237A5054702435 @default.
- W2155156237 hasAuthorship W2155156237A5060583781 @default.
- W2155156237 hasAuthorship W2155156237A5064424943 @default.
- W2155156237 hasConcept C112887158 @default.
- W2155156237 hasConcept C115624301 @default.
- W2155156237 hasConcept C178790620 @default.
- W2155156237 hasConcept C185592680 @default.
- W2155156237 hasConcept C191897082 @default.
- W2155156237 hasConcept C192562407 @default.
- W2155156237 hasConcept C199360897 @default.
- W2155156237 hasConcept C2776214540 @default.
- W2155156237 hasConcept C2777690519 @default.
- W2155156237 hasConcept C2779229104 @default.
- W2155156237 hasConcept C2781285689 @default.
- W2155156237 hasConcept C32909587 @default.
- W2155156237 hasConcept C41008148 @default.
- W2155156237 hasConcept C71240020 @default.
- W2155156237 hasConcept C8010536 @default.
- W2155156237 hasConceptScore W2155156237C112887158 @default.
- W2155156237 hasConceptScore W2155156237C115624301 @default.
- W2155156237 hasConceptScore W2155156237C178790620 @default.
- W2155156237 hasConceptScore W2155156237C185592680 @default.
- W2155156237 hasConceptScore W2155156237C191897082 @default.
- W2155156237 hasConceptScore W2155156237C192562407 @default.
- W2155156237 hasConceptScore W2155156237C199360897 @default.
- W2155156237 hasConceptScore W2155156237C2776214540 @default.
- W2155156237 hasConceptScore W2155156237C2777690519 @default.
- W2155156237 hasConceptScore W2155156237C2779229104 @default.
- W2155156237 hasConceptScore W2155156237C2781285689 @default.
- W2155156237 hasConceptScore W2155156237C32909587 @default.
- W2155156237 hasConceptScore W2155156237C41008148 @default.
- W2155156237 hasConceptScore W2155156237C71240020 @default.
- W2155156237 hasConceptScore W2155156237C8010536 @default.
- W2155156237 hasIssue "18" @default.
- W2155156237 hasLocation W21551562371 @default.
- W2155156237 hasOpenAccess W2155156237 @default.
- W2155156237 hasPrimaryLocation W21551562371 @default.
- W2155156237 hasRelatedWork W1991883810 @default.
- W2155156237 hasRelatedWork W2039374736 @default.
- W2155156237 hasRelatedWork W2041713713 @default.
- W2155156237 hasRelatedWork W2081734998 @default.
- W2155156237 hasRelatedWork W2167232069 @default.